117 related articles for article (PubMed ID: 2864551)
1. Absence of antibodies to LAV/HTLV-III in haemophiliacs treated with heat-treated factor VIII concentrate of American origin.
Felding P; Nilsson IM; Hansson BG; Biberfeld G
Lancet; 1985 Oct; 2(8459):832-3. PubMed ID: 2864551
[No Abstract] [Full Text] [Related]
2. Absence of seroconversion for HTLV-III in haemophiliacs intensively treated with heat treated factor VIII concentrate.
van der Meer J; Daenen S; van Imhoff GW; de Wolf JT; Halie MR
Br Med J (Clin Res Ed); 1986 Apr; 292(6527):1049. PubMed ID: 3008906
[No Abstract] [Full Text] [Related]
3. HTLV-III seropositivity in European haemophiliacs exposed to Factor VIII concentrate imported from the USA.
Melbye M; Froebel KS; Madhok R; Biggar RJ; Sarin PS; Stenbjerg S; Lowe GD; Forbes CD; Goedert JJ; Gallo RC
Lancet; 1984 Dec; 2(8417-8418):1444-6. PubMed ID: 6151053
[TBL] [Abstract][Full Text] [Related]
4. Seroconversion for HTLV-III since 1980 in British haemophiliacs.
Machin SJ; McVerry BA; Cheingsong-Popov R; Tedder RS
Lancet; 1985 Feb; 1(8424):336. PubMed ID: 2857382
[No Abstract] [Full Text] [Related]
5. Absence of antibodies to AIDS virus in haemophiliacs treated with heat-treated Factor VIII concentrate.
Rouzioux C; Chamaret S; Montagnier L; Carnelli V; Rolland G; Mannucci PM
Lancet; 1985 Feb; 1(8423):271-2. PubMed ID: 2857333
[No Abstract] [Full Text] [Related]
6. HTLV-III antibody and T-cell subset ratios in haemophiliacs and their spouses.
McVerry BA; Machin SJ; Galloway MJ; McCarthy K; Evans P; Barnes RM; Turner GC; Cheingsong-Popov R; Tedder RS; Winter M
Br J Haematol; 1986 Jun; 63(2):347-52. PubMed ID: 3013274
[TBL] [Abstract][Full Text] [Related]
7. Differential prevalence of antibody to AIDS-associated retrovirus in haemophiliacs treated with Factor VIII concentrate versus cryoprecipitate: recovery of infectious virus.
Koerper MA; Kaminsky LS; Levy JA
Lancet; 1985 Feb; 1(8423):275. PubMed ID: 2857339
[No Abstract] [Full Text] [Related]
8. Human T-lymphotropic retrovirus type III/lymphadenopathy-associated virus antibody. Association with hemophiliacs' immune status and blood component usage.
Jason J; McDougal JS; Holman RC; Stein SF; Lawrence DN; Nicholson JK; Dixon G; Doxey M; Evatt BL
JAMA; 1985 Jun; 253(23):3409-15. PubMed ID: 2987559
[TBL] [Abstract][Full Text] [Related]
9. Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the AIDS epidemic.
Evatt BL; Gomperts ED; McDougal JS; Ramsey RB
N Engl J Med; 1985 Feb; 312(8):483-6. PubMed ID: 2982095
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of HTLV-III/LAV antibodies in Italian asymptomatic hemophiliacs given commercial concentrates of factors VIII and IX.
Verani P; Mariani G; Mannucci PM; De Rossi G; Nicoletti L; Titti F; Falcione E; Pasqualetti D; Ammassari M; Gringeri A
J Med Virol; 1986 Jun; 19(2):143-9. PubMed ID: 3014059
[TBL] [Abstract][Full Text] [Related]
11. Abnormalities of in vitro immunoglobulin production in apparently healthy haemophiliacs: relationship with alterations of T cell subsets and with HTLV-III seropositivity.
Biagiotti R; Giudizi MG; Almerigogna F; Mazzetti M; Alessi A; Del Prete GF; Rafanelli D; Fiorilli M; Morfini M; Romagnani S
Clin Exp Immunol; 1986 Feb; 63(2):354-8. PubMed ID: 3009063
[TBL] [Abstract][Full Text] [Related]
12. A longitudinal study of patients with hemophilia: immunologic correlates of infection with HTLV-III/LAV and other viruses.
Stein SF; Evatt BL; McDougal JS; Lawrence DN; Holman RC; Ramsey RB; Spira TJ
Blood; 1985 Oct; 66(4):973-9. PubMed ID: 2994784
[TBL] [Abstract][Full Text] [Related]
13. Antibodies reactive with human T cell leukemia viruses in the serum of hemophiliacs receiving factor VIII concentrate.
Goedert JJ; Sarngadharan MG; Eyster ME; Weiss SH; Bodner AJ; Gallo RC; Blattner WA
Blood; 1985 Feb; 65(2):492-5. PubMed ID: 2981592
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to AIDS and heated factor VIII.
Mannucci PM; Gringeri A; Ammassari M
Lancet; 1985 Jun; 1(8444):1505-6. PubMed ID: 2861430
[No Abstract] [Full Text] [Related]
15. Antibodies against HTLV-III in Danish haemophiliacs: relation to source of factor VIII used in treatment and immunological parameters.
Lindhardt BO; Gerstoft J; Ulrich K; Bentzen K; Scheibel E; Dalsgård Nielsen J; Dickmeiss E
Scand J Haematol; 1985 Oct; 35(4):379-85. PubMed ID: 3001927
[TBL] [Abstract][Full Text] [Related]
16. HTLV-III/LAV antibodies and virus in hemophilia patients in Nebraska: survey and initiation of a prospective study.
Volsky DJ; Wu YT; Sinangil F; Goldsmith JC
AIDS Res; 1986 Feb; 2(1):51-61. PubMed ID: 2424467
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of antibodies to lymphadenopathy-AIDS virus in French haemophiliacs.
Aymard JP; Janot C; Chermann JC; Montagnier L; Briquel ME; Legras B; Alexandre P; Streiff F
Vox Sang; 1985; 49(2):161-3. PubMed ID: 2994302
[TBL] [Abstract][Full Text] [Related]
18. Use of heat-treated clotting-factor concentrates in patients with haemophilia and a high exposure to HTLV-III.
McGrath KM; Thomas KB; Herrington RW; Turner PJ; Taylor L; Ekert H; Schiff P; Gust ID
Med J Aust; 1985 Jul; 143(1):11-3. PubMed ID: 2989666
[TBL] [Abstract][Full Text] [Related]
19. Distribution of the level of antibody to AIDS-associated virus (LAV) in sera from AIDS or AIDS related complex and Japanese hemophiliacs infected with AIDS-associated virus.
Tsuchie H; Kawatani T; Nakayama E; Matsui T; Kurimura T; Hinuma Y
Microbiol Immunol; 1985; 29(11):1083-7. PubMed ID: 2869397
[TBL] [Abstract][Full Text] [Related]
20. Correlation of antibodies to LAV/HTLV III in hemophiliacs with the use of virus-inactivated clotting factors.
Dietz B; Klose HJ; Gürtler L; Eberle J; Deinhardt F; Köhler-Vajta K; Peller P
Thromb Haemost; 1986 Aug; 56(1):50-2. PubMed ID: 3095947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
